Department of Orthopaedics, Orthopedic Research Institute, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China.
West China Hospital, West China Medical School, Sichuan University, Chengdu, Sichuan Province, China.
Arthroscopy. 2022 Jul;38(7):2287-2302. doi: 10.1016/j.arthro.2022.01.048. Epub 2022 Feb 12.
To evaluate various radiofrequency ablation (RFA) treatments for knee osteoarthritis (OA) and determine the best modality, target, number of electrodes, and image guidance for improving knee pain and function.
Electronic databases were searched for randomized controlled trials (RCTs) comparing the efficacy of RFA treatments for knee OA from inception up to September 30, 2021. The primary outcome was the visual analog scale (VAS), and the secondary outcome was the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). Bayesian network meta-analysis was performed to synthesize the mean difference (MD) and rank the comparative effectiveness of treatments.
A total of 21 eligible RCTs (from 2011 to 2021, involving 1,818 patients) with 8 RFA treatments, 6 intra-articular injections, NSAIDS, exercise, and placebo were assessed. Conventional bipolar genicular nerve RFA (GNRFA) had the greatest net benefit on the VAS at 6 months (MD, -5.5; 95% confidence interval [CI], -4.3 to -6.7; SUCRA, .98). And cooled monopolar GNRFA had the greatest net benefit on the WOMAC at 6 months (MD, -33; 95% CI, -37 to -29; SUCRA, .99). In conventional and pulsed modalities, bipolar RFA was associated with a significant decrease in VAS and WOMAC than monopolar RFA. Combining pulsed intra-articular RFA and platelet-rich plasma injection had no additional positive effects on VAS or WOMAC at 3 months.
RFA is effective in improving both knee pain and function in patients with OA, at least in the short term (6 months). Patients respond better to the cooled modality than the conventional and pulsed modalities. Bipolar is more effective than monopolar for improving pain and function in conventional and pulsed modalities. Fluoroscopy and ultrasound guidance showed no differences in improving pain and function. The effectiveness of RFA in cooled modality using bipolar or in combination with various intra-articular injections remains to be compared.
II, systematic review and meta-analysis of Level I and II studies.
评估各种射频消融 (RFA) 治疗膝关节骨关节炎 (OA) 的效果,并确定改善膝关节疼痛和功能的最佳方式、靶点、电极数量和图像引导。
电子数据库检索了从 2011 年到 2021 年期间比较 RFA 治疗膝 OA 疗效的随机对照试验 (RCT)。主要结局是视觉模拟评分 (VAS),次要结局是西安大略和麦克马斯特大学骨关节炎指数 (WOMAC)。采用贝叶斯网络荟萃分析综合平均差 (MD),并对治疗效果进行排序。
共纳入 21 项符合条件的 RCT(2011 年至 2021 年,涉及 1818 例患者),包括 8 种 RFA 治疗、6 种关节内注射、非甾体抗炎药、运动和安慰剂。常规双极关节内神经 RFA (GNRFA) 在 6 个月时对 VAS 的净获益最大 (MD,-5.5;95%置信区间 [CI],-4.3 至-6.7;SUCRA,.98)。冷却单极 GNRFA 在 6 个月时对 WOMAC 的净获益最大 (MD,-33;95%CI,-37 至-29;SUCRA,.99)。在常规和脉冲模式下,双极 RFA 与单极 RFA 相比,VAS 和 WOMAC 显著降低。在 3 个月时,脉冲关节内 RFA 联合富含血小板的血浆注射对 VAS 或 WOMAC 没有额外的积极影响。
RFA 至少在短期 (6 个月)内有效改善 OA 患者的膝关节疼痛和功能。与传统和脉冲模式相比,患者对冷却模式的反应更好。在传统和脉冲模式中,双极比单极更有效改善疼痛和功能。透视和超声引导在改善疼痛和功能方面没有差异。在冷却模式下使用双极或联合各种关节内注射的 RFA 的有效性仍有待比较。
II,对 I 级和 II 级研究的系统评价和荟萃分析。